Virax Biolabs Group Limited Ordinary Shares
VRAXVirax Biolabs Group Limited is a biotechnology company that focuses on the development, manufacturing, and commercialization of vaccines and diagnostic products. The company aims to address infectious diseases through innovative health solutions, leveraging advanced technologies to improve global health outcomes.
Company News
Virax Biolabs Group Limited has entered into agreements for a private placement of 12,500,000 ordinary shares and preferred investment options at $0.40 per share, expecting to raise $5 million for working capital and corporate purposes.
Saudi Arabia made its debut at the BIO International Convention 2025, signing over a dozen partnerships, launching a national biotech accelerator program, and establishing the Kingdom as a global hub for life sciences. The Kingdom showcased its ecosystem ready for collaboration across scientific discovery, clinical research, and advanced therapeu...
Hot penny stocks to watch this week The post Penny Stocks To Buy Before 2024? 3 For Your Watch List Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
New York City is ending its COVID vaccine mandate for public-sector workers this week, including police officers, firefighters and teachers.
